Champions Oncology News

12,14 $ -4,93% -0,63 $
In Euro: 10,585 € | 22.10.18 22:00:00 Uhr Nasdaq | Mehr Kurse »
ISIN: US15870P1093
US-Symbol: CSBR
Typ: Aktie

Champions Oncology News

  
21.01.16 Champions Oncology Announces Initiation of Prospective Correlative Trial in Sarcoma PR Newswire
14.12.15 Champions Oncology Leading Paradigm Shift to Incorporation of PDX Models into Clinical Trial Strategy PR Newswire
10.09.15 Champions Oncology Reports Results for the First Quarter Ended July 31, 2015 PR Newswire
08.09.15 Champions Oncology to Announce First Quarter Financial Results on Thursday, September 10, 2015 PR Newswire
21.08.15 Champions Oncology Announces Uplisting to NASDAQ PR Newswire
17.08.15 Champions Oncology Files Patents for Use of PDX Platform in Immune-​Oncology PR Newswire
12.08.15 /C O R R E C T I O N -- Champions Oncology, Inc./ PR Newswire
12.08.15 Champions Oncology Announces Reverse Stock Split in Preparation for Uplisting to NASDAQ PR Newswire
05.08.15 Champion Oncology Announces Additions to Leadership Team to Support Continued Growth PR Newswire
28.07.15 Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2015 PR Newswire
24.07.15 Champions Oncology to Announce Fourth Quarter Financial Results on Tuesday, July 28 PR Newswire
24.07.14 Champions Oncology Reports Results for Quarter and Full Year Ended April 30, 2014 PR Newswire
21.07.14 Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 24 PR Newswire
17.06.14 Icahn School of Medicine at Mount Sinai and Champions Oncology Initiate Study Evaluating TumorGrafts' Ability to Predict Treatment Benefit in Patients with Triple-​Negative Breast Cancer PR Newswire
30.04.14 Integrating Next-​Generation Sequencing and Champions Oncology's TumorGrafts Provides Highly Accurate Prediction of Cancer Treatment Benefit, According to Results Published in Clinical Cancer Research PR Newswire
08.04.14 Publication of Article in Cancer Supports Use of Personalized Mouse Avatars to Predict Treatment Benefit in Patients PR Newswire
04.04.14 Champions Oncology to Present Posters on TumorGraft Application in Clinical and Research Settings at AACR Annual Meeting 2014 PR Newswire
13.03.14 Champions Oncology Reports Results for the Third Quarter Ended January 31, 2014 PR Newswire
10.03.14 Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 13 PR Newswire
04.03.14 Champions Oncology Expands Oncology Data Processing Capabilities with Appointment of Ido Ben-Zvi, Ph.D., as Director of Bioinformatics and Machine Learning PR Newswire
26.02.14 Leading Regional Hospital Network in Asia to Offer Champions TumorGraft™ to Cancer Patients PR Newswire
06.01.14 Champions Oncology Names Angela Davies, M.D., Chief Medical Officer PR Newswire
14.12.12 Champions Oncology Reports Financial Results for the Quarter Ended October 31, 2012 PR Newswire
27.09.12 Champions Oncology Notes Front Page Article Discussing Personalized TumorGraft In The New York Times PR Newswire
12.09.12 Champions Oncology Reports Financial Results for the Quarter Ended July 31, 2012 PR Newswire
07.09.12 Champions Oncology to Present at Rodman & Renshaw Conference PR Newswire
03.08.12 Champions Oncology Reports Resignation Of Director PR Newswire
19.07.12 Champions Oncology Reports Financial Results for the Year Ended April 30, 2012 PR Newswire

Newssuche